By analyzing dozens of laboratory and animal studies, researchers found that GLP-1 receptor agonists consistently lower the brain proteins responsible for the progression of this dementia
In this, pentadecapeptide BPC 157 consistently (grossly, microscopically, and biomechanically) cured burn injuries, and counteracted corticosteroid (6-methylprednisolone 1.0 or 10 mg/kg/day ip for 21 days)-induced impairment of burn healing (Mikus et al., 2001
2,5 Commercially successful GLP-1 RAs include: Patent Landscape: Expiry Forecast and Challenges The global success of GLP-1 therapies has also intensified focus on intellectual property protection
Shantavasinkul PC, Omotosho P, Muehlbauer MJ, Natoli M, Corsino L, Tong J, et al
10.1007/s00125-011-2241-2 31
Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults